Holly McCoppin, MD
Dermatology · Loveland, CONPI 1003011404
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 437 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations.
Across 437 payments — averaging $19.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Sanofi$943
- Lilly USA, LLC$883
- Sun Pharmaceutical Industries Inc.$853
- Novartis$507
- Johnson & Johnson$423
- plus $3K from 28 others
What the payments were for
- Food & beverage$8,24698%
- Education$1652%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 103 | $1,762 |
| Sanofi | 40 | $943 |
| Lilly USA, LLC | 55 | $883 |
| Sun Pharmaceutical Industries Inc. | 47 | $853 |
| Novartis | 27 | $507 |
| Johnson & Johnson | 18 | $423 |
| Regeneron Healthcare Solutions, Inc. | 15 | $415 |
| UCB, Inc. | 13 | $332 |
| LEO Pharma Inc. | 11 | $302 |
| Galderma Laboratories, L.p. | 19 | $296 |
| Pfizer | 18 | $291 |
| Amgen | 10 | $239 |
| E.r. Squibb & Sons, L.L.C. | 9 | $183 |
| Incyte Corporation | 8 | $133 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 7 | $118 |
| Almirall LLC | 5 | $98 |
| Organon | 5 | $87 |
| Dermira, Inc. | 3 | $64 |
| Biocon Biologics Inc | 2 | $55 |
| Dermavant Sciences, Inc. | 3 | $54 |
| Convatec Inc. | 1 | $44 |
| Acera Surgical, Inc. | 2 | $41 |
| Biofrontera Inc. | 2 | $41 |
| VYNE Pharmaceuticals Inc. | 2 | $37 |
| Verrica Pharmaceuticals Inc. | 2 | $36 |
| Arcutis Biotherapeutics, Inc. | 2 | $28 |
| Dilon Technologies, Inc. | 1 | $22 |
| Mylan Institutional Inc. | 1 | $21 |
| Mylan Pharmaceuticals Inc. | 1 | $21 |
| Boehringer Ingelheim | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| EPI Health, LLC | 1 | $16 |
| Mayne Pharma Commercial LLC | 1 | $15 |
| Journey Medical Corporation | 1 | $12 |
How this compares
$8,411 in reported general payments places this provider in the 80th percentile of 280 dermatology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 39 | $1,414 |
| Fluorouracil | 18 | $1,384 |
| Ketoconazole | 49 | $949 |
| Mupirocin | 59 | $509 |
| Triamcinolone Acetonide | 42 | $507 |
| Ciclopirox | 19 | $417 |
| Cephalexin | 72 | $321 |
| Dutasteride | 17 | $278 |
| Terbinafine Hcl | 21 | $141 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $119 |
| Minoxidil | 18 | $117 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Loveland
- Ammon LarsenLoveland$620K
- Marcjonathan SerotaLittleton$3.2M
- Victoria MossColorado Springs$473K
- Sheila BoyleWestminster$240K
- Mary Margaret KoberGlenwood Springs$202K
- Cathy KogerBoulder$182K
- Mona SadeghpourLone Tree$159K
- David NorrisAurora$156K
- Drew TaylorDenver$135K
- Dawnielle EndlyAurora$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.